V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003497 | 210012930 | 1.63 | 95.2 | null | null | 2021-07-31 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 101680730 |
| 210003501 | 210012931 | 1.6 | 83.7 | Palliative (P) | 2020-10-14 | 2020-11-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101043228 |
| 210003504 | 210012933 | 1.77 | 55.2 | Curative (C) | null | 2018-11-05 | Docetaxel | 01 | N | DOCETAXEL | 101572966 |
| 210003511 | 210012934 | 1.55 | null | Neo-adjuvant (N) | null | 2018-02-13 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 101358189 |
| 210003512 | 210012935 | 1.77 | 88.9 | null | 2019-09-20 | 2019-12-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101860377 |
| 210003515 | 210012936 | 1.69 | 99.2 | null | 2018-12-19 | 2019-02-27 | Trastuzumab | 02 | N | TRASTUZUMAB | 100708990 |
| 210003523 | 210012937 | 1.55 | 104.25 | Neo-adjuvant (N) | 2020-02-17 | 2020-04-22 | Docetaxel | 02 | N | DOCETAXEL | 101699740 |
| 210003534 | 210012940 | 1.65 | 76.6 | null | 2020-01-31 | 2020-04-30 | Docetaxel | 02 | N | DOCETAXEL | 100107612 |
| 210003539 | 210012942 | null | null | null | 2021-08-27 | 2021-08-28 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101108235 |
| 210003542 | 210012944 | 1.88 | 61.4 | Adjuvant (A) | null | 2020-03-14 | Docetaxel | 02 | null | DOCETAXEL | 101043355 |
| 210003551 | 210012947 | 1.6 | null | Adjuvant (A) | null | 2020-09-12 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100945543 |
| 210003561 | 210012948 | 1.61 | 77.7 | Neo-adjuvant (N) | 2017-04-13 | 2017-06-25 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100160981 |
| 210003582 | 210012952 | 1.69 | 85 | Adjuvant (A) | null | 2018-10-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 101592335 |
| 210003588 | 210012953 | 1.49 | 50.4 | Neo-adjuvant (N) | 2019-01-12 | 2019-04-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100005171 |
| 210003594 | 210012955 | 1.73 | 62.3 | Adjuvant (A) | null | 2018-09-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101091458 |
| 210003596 | 210012956 | null | 66.4 | Adjuvant (A) | null | 2017-10-20 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100932729 |
| 210003607 | 210012957 | 1.62 | 71.2 | Adjuvant (A) | null | 2018-11-30 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100594441 |
| 210003608 | 210012958 | 1.63 | 67.55 | Adjuvant (A) | null | 2018-11-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101459971 |
| 210003614 | 210012960 | 1.66 | 89.35 | Neo-adjuvant (N) | 2021-01-07 | 2021-01-23 | GemCarbo Days 1+8 | null | N | PALBOCICLIB | 100051436 |
| 210003616 | 210012961 | null | null | null | null | 2020-01-11 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101600708 |
| 210003619 | 210012962 | null | 62.4 | null | 2018-10-04 | 2018-10-07 | null | null | null | CARBOPLATIN + PACLITAXEL | 100762088 |
| 210003622 | 210012963 | null | null | null | 2018-10-24 | 2018-12-21 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 100628901 |
| 210003633 | 210012966 | 1.55 | 89 | Palliative (P) | 2014-08-03 | 2017-10-20 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100306543 |
| 210003634 | 210012967 | null | null | null | 2017-12-30 | 2018-01-29 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 101537298 |
| 210003635 | 210012968 | 1.66 | 53 | Neo-adjuvant (N) | 2016-04-14 | 2016-06-09 | Pertuzumab (Maintenance) | null | N | PERTUZUMAB | 101110095 |
| 210003637 | 210012969 | 1.66 | 66.2 | Unknown (U) | null | 2021-08-05 | Capecitabine | 02 | N | CAPECITABINE | 100715250 |
| 210003645 | 210012973 | 1.6 | 74.4 | Adjuvant (A) | 2020-03-04 | 2020-06-02 | Epirubicin | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100213240 |
| 210003649 | 210012976 | null | null | Adjuvant (A) | 2021-12-27 | 2021-12-31 | VINORELBINE | 02 | N | VINORELBINE | 101499191 |
| 210003654 | 210012977 | 0 | 84 | Palliative (P) | 2022-03-02 | 2022-05-05 | SACITUZUMAB GOVITECAN | 02 | N | TRASTUZUMAB EMTANSINE | 101430286 |
| 210003655 | 210012978 | 1.57 | 131 | Palliative (P) | null | 2020-03-10 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100450128 |
| 210003661 | 210012979 | 1.63 | 66.6 | Curative (C) | null | 2021-07-01 | EVEROLIMUS | 02 | N | NAB-PACLITAXEL | 101142984 |
| 210003662 | 210012980 | 1.73 | 144.4 | Palliative (P) | 2018-04-11 | 2018-07-04 | Capecitabine | 02 | N | CAPECITABINE | 100138986 |
| 210003667 | 210012981 | 1.59 | 75 | null | null | 2021-03-22 | null | null | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100691223 |
| 210003669 | 210012983 | 1.42 | 95.8 | Palliative (P) | 2018-12-25 | 2019-03-05 | Liposomal Doxorubicin (Caelyx) | 02 | N | TRIAL UNSPECIFIED | 101195971 |
| 210003675 | 210012985 | 1.57 | 70 | Neo-adjuvant (N) | 2017-05-02 | 2017-05-02 | Letrozole + Palbociclib | 01 | N | CARBOPLATIN + PACLITAXEL | 100967742 |
| 210003677 | 210012986 | 1.54 | 76.1 | Neo-adjuvant (N) | null | 2019-08-15 | Letrozole + Palbociclib | 02 | N | ABEMACICLIB | 101174176 |
| 210003686 | 210012989 | null | null | Adjuvant (A) | 2020-12-31 | 2021-01-14 | null | 02 | N | EPIRUBICIN | 101457830 |
| 210003689 | 210012990 | 1.7 | 82.5 | Palliative (P) | 2021-02-22 | 2021-03-15 | Pertuzumab (Maintenance) | 02 | N | PERTUZUMAB | 101857012 |
| 210003690 | 210012991 | 1.7 | 54.95 | null | 2021-12-11 | 2022-01-03 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 100856400 |
| 210003691 | 210012992 | 1.67 | 53.6 | Palliative (P) | 2019-04-19 | 2019-05-03 | ABEMACICLIB + FULVESTRANT | 02 | N | FEC | 100478792 |
| 210003693 | 210012993 | 1.63 | 56.6 | Neo-adjuvant (N) | 2020-05-19 | 2020-09-02 | CARBOPLATIN | 02 | N | TRASTUZUMAB EMTANSINE | 100959064 |
| 210003697 | 210012994 | 1.7 | 68.8 | null | 2017-10-12 | 2017-12-21 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100712049 |
| 210003698 | 210012995 | 1.63 | 55 | Adjuvant (A) | 2020-12-23 | 2021-04-03 | null | null | N | ABEMACICLIB + FULVESTRANT | 100105527 |
| 210003703 | 210012996 | null | null | Neo-adjuvant (N) | null | 2020-12-15 | Neratinib | 02 | N | NERATINIB | 101702403 |
| 210003712 | 210012997 | 1.69 | 90.2 | Adjuvant (A) | 2020-08-08 | 2020-08-18 | Capecitabine | 02 | null | CAPECITABINE | 101840371 |
| 210003714 | 210012998 | 1.66 | 62.8 | null | 2021-11-18 | 2022-05-08 | null | 02 | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 101340915 |
| 210003716 | 210012999 | 0 | 127.9 | Palliative (P) | null | 2021-01-31 | TCH (21 day Trastuzumab) Maint | null | N | CARBOPLATIN + PACLITAXEL | 100856886 |
| 210003717 | 210013000 | 1.74 | 56.7 | null | 2020-11-27 | 2020-12-14 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + GEMCITABINE | 100417507 |
| 210003719 | 210013001 | 1.58 | 47.2 | Neo-adjuvant (N) | null | 2019-07-17 | EC | null | N | EC | 101426308 |
| 210003721 | 210013003 | null | null | null | null | 2020-05-24 | Cyclophosphamide + Docetaxel | null | null | EPIRUBICIN | 100577965 |